- Home
- TPST vs IRIX Comparison
TPST vs IRIX Comparison
Compare TPST & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPST
- IRIX
- Stock Information
- Founded
- TPST 2011
- IRIX 1989
- Country
- TPST United States
- IRIX United States
- Employees
- TPST N/A
- IRIX N/A
- Industry
- TPST Biotechnology: Pharmaceutical Preparations
- IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- TPST Health Care
- IRIX Health Care
- Exchange
- TPST Nasdaq
- IRIX Nasdaq
- Market Cap
- TPST 27.2M
- IRIX 28.6M
- IPO Year
- TPST N/A
- IRIX 1996
- Fundamental
- Price
- TPST $0.70
- IRIX $1.69
- Analyst Decision
- TPST Strong Buy
- IRIX Hold
- Analyst Count
- TPST 4
- IRIX 1
- Target Price
- TPST $20.00
- IRIX $2.00
- AVG Volume (30 Days)
- TPST 1.4M
- IRIX 20.6K
- Earning Date
- TPST 11-12-2024
- IRIX 11-12-2024
- Dividend Yield
- TPST N/A
- IRIX N/A
- EPS Growth
- TPST N/A
- IRIX N/A
- EPS
- TPST N/A
- IRIX N/A
- Revenue
- TPST N/A
- IRIX $48,431,000.00
- Revenue This Year
- TPST N/A
- IRIX N/A
- Revenue Next Year
- TPST N/A
- IRIX $5.44
- P/E Ratio
- TPST N/A
- IRIX N/A
- Revenue Growth
- TPST N/A
- IRIX N/A
- 52 Week Low
- TPST $0.70
- IRIX $1.27
- 52 Week High
- TPST $6.00
- IRIX $3.65
- Technical
- Relative Strength Index (RSI)
- TPST 24.08
- IRIX 50.88
- Support Level
- TPST $0.86
- IRIX $1.61
- Resistance Level
- TPST $0.86
- IRIX $1.82
- Average True Range (ATR)
- TPST 0.07
- IRIX 0.08
- MACD
- TPST -0.01
- IRIX -0.02
- Stochastic Oscillator
- TPST 0.00
- IRIX 35.94
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
About IRIX IRIDEX Corporation
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.